Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The development of novel pharmaceuticals often relies on key chemical intermediates that possess unique biological activities. 7,8-Dihydroxyflavone (7,8-DHF) is one such compound, recognized for its significant role as a TrkB receptor agonist and its ability to mimic Brain-Derived Neurotrophic Factor (BDNF). Its potential in treating various neurological disorders makes it a valuable asset in drug development pipelines. NINGBO INNO PHARMCHEM CO., LTD., a leading pharmaceutical intermediate supplier in China, is dedicated to providing this high-quality compound to the global research community.
7,8-DHF: A Key Intermediate with Therapeutic Promise
BDNF is critical for neuronal health, but its direct use as a therapeutic is hindered by its poor pharmacokinetic profile. 7,8-Dihydroxyflavone bridges this gap by acting as a potent and selective small-molecule agonist of the TrkB receptor, the main signaling receptor for BDNF. This mimicry allows 7,8-DHF to elicit similar beneficial effects, including neuroprotection and enhanced synaptic plasticity, without the limitations of protein-based therapies. Its oral bioavailability and capacity to cross the blood-brain barrier further enhance its therapeutic potential for a range of CNS conditions, from Alzheimer's and Parkinson's diseases to depression.
The Significance of TrkB Agonists in Drug Development
The development of effective treatments for neurodegenerative diseases is a major focus in pharmaceutical research. TrkB agonists like 7,8-DHF represent a promising strategy. By targeting the BDNF signaling pathway, these compounds can potentially:
The research into 7,8-dihydroxyflavone continues to uncover new therapeutic avenues, making it a crucial intermediate for companies developing next-generation neurological drugs.
Reliable Sourcing from NINGBO INNO PHARMCHEM CO., LTD.
For pharmaceutical companies and research institutions, sourcing reliable and high-purity pharmaceutical intermediates is paramount. NINGBO INNO PHARMCHEM CO., LTD., a distinguished manufacturer in China, is committed to delivering exceptional quality 7,8-Dihydroxyflavone. We understand the stringent requirements of drug development and ensure our products meet the highest standards. If you are seeking to buy/purchase this vital compound, our company offers a dependable supply chain and technical expertise to support your R&D efforts, helping to accelerate the journey from laboratory discovery to clinical application.
Partnering with NINGBO INNO PHARMCHEM CO., LTD. ensures you have a trusted source for 7,8-Dihydroxyflavone, a compound poised to make significant contributions to neurological medicine.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
